6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane

C106H117Br2F3IN23O4 — CID 158103606

IUPAC6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane
SMILESBrc1cn2c(I)cnc2c(NCCc2c[nH]c3ccccc23)n1.C.C=C(C)CCOCC.C=C(CCOCC)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(F)c3)cn12.C=C(CCOCC)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(Br)cn12.CCOCCC(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(F)c3)cn12.Cc1cncc(F)c1
InChIInChI=1S/C27H29FN6O.C27H27FN6O.C22H24BrN5O.C16H13BrIN5.C7H14O.C6H6FN.CH4/c2*1-3-35-11-9-18(2)25-16-32-27-26(30-10-8-19-14-31-23-7-5-4-6-22(19)23)33-24(17-34(25)27)20-12-21(28)15-29-13-20;1-3-29-11-9-15(2)19-13-26-22-21(27-20(23)14-28(19)22)24-10-8-16-12-25-18-7-5-4-6-17(16)18;17-13-9-23-14(18)8-21-16(23)15(22-13)19-6-5-10-7-20-12-4-2-1-3-11(10)12;1-4-8-6-5-7(2)3;1-5-2-6(7)4-8-3-5;/h4-7,12-18,31H,3,8-11H2,1-2H3,(H,30,33);4-7,12-17,31H,2-3,8-11H2,1H3,(H,30,33);4-7,12-14,25H,2-3,8-11H2,1H3,(H,24,27);1-4,7-9,20H,5-6H2,(H,19,22);2,4-6H2,1,3H3;2-4H,1H3;1H4
InChIKeyFPOJUTFZAYTCFP-UHFFFAOYSA-N
MW2120.96 g/mol
LogP24.56
Rot. Bonds37

About 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane

6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane (PubChem CID 158103606) has the molecular formula C106H117Br2F3IN23O4 and a molecular weight of 2120.96 g/mol. Its IUPAC name is 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane.

Molecular Properties

Compound Name6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane
PubChem CID158103606
Molecular FormulaC106H117Br2F3IN23O4
Molecular Weight2120.96 g/mol
Exact Mass2117.70
IUPAC Name6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane
SMILESBrc1cn2c(I)cnc2c(NCCc2c[nH]c3ccccc23)n1.C.C=C(C)CCOCC.C=C(CCOCC)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(F)c3)cn12.C=C(CCOCC)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(Br)cn12.CCOCCC(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(F)c3)cn12.Cc1cncc(F)c1
InChIInChI=1S/C27H29FN6O.C27H27FN6O.C22H24BrN5O.C16H13BrIN5.C7H14O.C6H6FN.CH4/c2*1-3-35-11-9-18(2)25-16-32-27-26(30-10-8-19-14-31-23-7-5-4-6-22(19)23)33-24(17-34(25)27)20-12-21(28)15-29-13-20;1-3-29-11-9-15(2)19-13-26-22-21(27-20(23)14-28(19)22)24-10-8-16-12-25-18-7-5-4-6-17(16)18;17-13-9-23-14(18)8-21-16(23)15(22-13)19-6-5-10-7-20-12-4-2-1-3-11(10)12;1-4-8-6-5-7(2)3;1-5-2-6(7)4-8-3-5;/h4-7,12-18,31H,3,8-11H2,1-2H3,(H,30,33);4-7,12-17,31H,2-3,8-11H2,1H3,(H,30,33);4-7,12-14,25H,2-3,8-11H2,1H3,(H,24,27);1-4,7-9,20H,5-6H2,(H,19,22);2,4-6H2,1,3H3;2-4H,1H3;1H4
InChIKeyFPOJUTFZAYTCFP-UHFFFAOYSA-N
XLogP24.56
TPSA307.63 Ų
H-Bond Donors8
H-Bond Acceptors23
Rotatable Bonds37
Heavy Atoms139
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002120.96
LogP ≤ 524.56
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane?
The IUPAC name of 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane (CID 158103606) is 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane.
What is the SMILES notation for 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane?
The canonical SMILES for 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane is Brc1cn2c(I)cnc2c(NCCc2c[nH]c3ccccc23)n1.C.C=C(C)CCOCC.C=C(CCOCC)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(F)c3)cn12.C=C(CCOCC)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(Br)cn12.CCOCCC(C)c1cnc2c(NCCc3c[nH]c4ccccc34)nc(-c3cncc(F)c3)cn12.Cc1cncc(F)c1.
What is the InChIKey of 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane?
The InChIKey is FPOJUTFZAYTCFP-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H29FN6O.C27H27FN6O.C22H24BrN5O.C16H13BrIN5.C7H14O.C6H6FN.CH4/c2*1-3-35-11-9-18(2)25-16-32-27-26(30-10-8-19-14-31-23-7-5-4-6-22(19)23)33-24(17-34(25)27)20-12-21(28)15-29-13-20;1-3-29-11-9-15(2)19-13-26-22-21(27-20(23)14-28(19)22)24-10-8-16-12-25-18-7-5-4-6-17(16)18;17-13-9-23-14(18)8-21-16(23)15(22-13)19-6-5-10-7-20-12-4-2-1-3-11(10)12;1-4-8-6-5-7(2)3;1-5-2-6(7)4-8-3-5;/h4-7,12-18,31H,3,8-11H2,1-2H3,(H,30,33);4-7,12-17,31H,2-3,8-11H2,1H3,(H,30,33);4-7,12-14,25H,2-3,8-11H2,1H3,(H,24,27);1-4,7-9,20H,5-6H2,(H,19,22);2,4-6H2,1,3H3;2-4H,1H3;1H4.
What are the key properties of 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane?
6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane has a molecular weight of 2120.96 g/mol, XLogP of 24.56, 37 rotatable bonds, 8 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-3-(4-ethoxybut-1-en-2-yl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;6-bromo-N-[2-(1H-indol-3-yl)ethyl]-3-iodoimidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybutan-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;3-(4-ethoxybut-1-en-2-yl)-6-(5-fluoro-3-pyridinyl)-N-[2-(1H-indol-3-yl)ethyl]imidazo[1,2-a]pyrazin-8-amine;4-ethoxy-2-methylbut-1-ene;3-fluoro-5-methylpyridine;methane is sourced from PubChem (CID 158103606), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).